美国肥胖与非酒精性脂肪性肝炎相关肝移植等待名单新增人数预计增加
该研究利用2000至2014年美国器官获取与移植网络数据,结合人口普查局与国民健康营养调查的肥胖数据,建立肥胖患病率与NASH相关等待名单新增之间的9年时间滞后关系。结果显示肥胖比例增加44.9%,NASH相关年新增从391例增至1605例,预计2016至2030年新增将增加55.4%(1354-2104),且存在显著地区差异(P < 0.01)。
要点
- 2000至2014年肥胖比例增加44.9%,NASH相关年等待名单新增从391例增至1605例。
- 肥胖患病率与9年后肝移植等待名单新增强相关(推导与验证队列R²=0.9)。
- 预计2016至2030年NASH相关年新增增加55.4%(1354-2104),地区差异显著(P < 0.01)。
核心结论
- 基于人群肥胖趋势,预计NASH相关肝移植需求将显著增加。
- 需要持续的公共卫生努力遏制肥胖患病率,以减少未来NASH负担。
研究设计与样本
- 使用美国器官获取与移植网络数据库2000至2014年数据获取NASH相关肝移植等待名单新增数量。
- 使用美国人口普查局与国民健康营养调查数据估计2000至2014年肥胖人群。
- 基于肥胖趋势建立肥胖患病率与NASH相关等待名单新增之间的时间滞后。
- 使用美国人口普查局2016至2030年人口预测数据预测肥胖与NASH相关等待名单新增。
主要发现
- 2000至2014年肥胖个体比例显著增加44.9%。
- NASH相关年等待名单新增从391例增至1605例。
- 肥胖患病率增加与9年后肝移植等待名单新增强相关(推导与验证队列R²=0.9)。
- 预计2016至2030年NASH相关年等待名单新增增加55.4%(1354-2104)。
- 肥胖率与NASH相关等待名单新增预计增幅存在显著地区差异(P < 0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nonalcoholic steatohepatitis (NASH) cirrhosis is the fastest growing indication for liver transplantation (LT) in the United States. We aimed to determine the temporal trend behind the rise in obesity and NASH-related additions to the LT waitlist in the United States and make projections for future NASH burden on the LT waitlist. We used data from the Organ Procurement and Transplantation Network database from 2000 to 2014 to obtain the number of NASH-related LT waitlist additions. The obese population in the United States from 2000 to 2014 was estimated using data from the U.S. Census Bureau and the National Health and Nutrition Examination Survey. Based on obesity trends, we established a time lag between obesity prevalence and NASH-related waitlist additions. We used data from the U.S. Census Bureau on population projections from 2016 to 2030 to forecast obesity estimates and NASH-related LT waitlist additions. From 2000 to 2014, the proportion of obese individuals significantly increased 44.9% and the number of NASH-related annual waitlist additions increased from 391 to 1,605. Increase in obesity prevalence was strongly associated with LT waitlist additions 9 years later in derivation and validation cohorts (R2 = 0.9). Based on these data, annual NASH-related waitlist additions are anticipated to increase by 55.4% (1,354-2,104) between 2016 and 2030. There is significant regional variation in obesity rates and in the anticipated increase in NASH-related waitlist additions (P < 0.01). Conclusion: We project a marked increase in demand for LT for NASH given population obesity trends. Continued public health efforts to curb obesity prevalence are needed to reduce the projected future burden of NASH. (Hepatology 2017).
引用
- Parikh ND, Marrero WJ, Wang J, et al. Projected increase in obesity and non-alcoholic-steatohepatitis-related liver transplantation waitlist additions in the United States. Hepatology. 2018. PMID: 28833326. doi:10.1002/hep.29473
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。